PrimeX News

S&P 500 and Dow Jones Forecast: Stocks Face Inflation Risk Despite Trade Relief
Sat, 27 Jun 2026 09:37:25 GMT
Nokia (NOK) Price Forecast: Head and Shoulders Signals Deeper Pullback
Fri, 26 Jun 2026 20:59:36 GMT
Gold (XAU/USD) Price Forecast: Trendline Break Signals Bearish Extension
Fri, 26 Jun 2026 20:46:30 GMT
Natural Gas Price Forecast: Can Bulls Break $3.44 Ceiling?
Fri, 26 Jun 2026 20:34:11 GMT
Gold’s Summer Pullback May Be the Last Great Buying Opportunity Before New 2026 Highs
Fri, 26 Jun 2026 19:55:29 GMT
Oil News: Crude Oil Futures Sink Below 200-Day Average on Oil Demand Fears
Fri, 26 Jun 2026 19:48:58 GMT

From Currencies to Commodities: Leveraging Gold Ratios in Trading
Thu, 25 Jun 2026 12:59:13 GMT
First Light News: Trump Puts Pen to Paper & the Fed Comes in Hawkish
Thu, 18 Jun 2026 08:20:37 GMT
ECB, Bank of England Set to Hold Rates Unchanged Today
Thu, 11 Jun 2026 17:21:35 GMT
Nasdaq 100: Meta Falls as Amazon Slips, Microsoft, Alphabet Diverge
Wed, 29 Apr 2026 21:43:04 GMT
Hungary’s Euro Ambition Is a Long-term Bet Requiring Discipline, Credibility and Integration
Thu, 11 Jun 2026 17:22:50 GMT
A Divided Fed to Continue Favouring Easing Even as the Iran War Raises the Stakes
Thu, 11 Jun 2026 17:20:25 GMT

Seasonality and Event-Driven Trades in ETFs: How to Spot Recurring Trading Opportunities
Fri, 19 Jun 2026 23:26:11 GMT
Building and Risk-Managing Multi-Asset Portfolios with ETFs
Fri, 19 Jun 2026 20:08:58 GMT
What Really Drives ETF Performance: Rebalancing, Dividends, Fees, and Tracking Error
Tue, 23 Jun 2026 13:26:26 GMT
Trading Volume Explained: Why it Matters for Breakouts, Reversals and Trends
Wed, 10 Jun 2026 00:40:01 GMT
RSI Indicator Explained: How to Read Momentum and Time Trades in 2026
Wed, 03 Jun 2026 21:56:39 GMT
Fibonacci Retracements Explained: How to Spot Key Reversal Levels in 2026
Thu, 28 May 2026 12:22:53 GMT

Advertisement

Advertisement

IBRX

ImmunityBio, Inc. Common Stock

8.71

USD

+0.92

+11.81%

Jun 26, 16:00 UTC -4

Closed

exchange

After-Market

8.48

-0.23

-2.64%

IBRX News & Forecasts

featured

Zacks Investment Research

IBRX and the BCG Shortage: Deals That Could Expand Demand

featured

Zacks Investment Research

ImmunityBio: Anktiva Explained and What Comes Next

featured

Zacks Investment Research

IBRX Stock Outlook After Q1 Results and a New FDA Review

featured

ImmunityBio: Could Be One Approval Away From A Multi-Billion Dollar Breakout

featured

Zacks Investment Research

FDA Accepts IBRX's Filing Seeking Expanded Use of Bladder Cancer Therapy

featured

ImmunityBio Stock Climbs As FDA Accepts Expanded Use Filing For Bladder Cancer Drug

featured

ImmunityBio Says ANKTIVA Combo Outperformed Rival Bladder Cancer Therapies

featured

Zacks Investment Research

ImmunityBio Secures Five U.S. Patents for Anktiva in Bladder Cancer

featured

ImmunityBio: Looking Beyond Bladder Cancer To A Multibillion-Dollar Solid Tumor TAM

featured

ImmunityBio Stock Drops After Earnings Miss Despite Anktiva Momentum

featured

Zacks Investment Research

ImmunityBio (IBRX) Reports Q1 Loss, Tops Revenue Estimates

featured

Zacks Investment Research

ImmunityBio to Report Q1 Earnings: What's in the Cards?

featured

Zacks Investment Research

IBRX Global Rollout: EU, MENA, and Asia Shape 2026-27 Catalysts

featured

Zacks Investment Research

IBRX: What Anktiva's Bladder Data Says About 2026 Sales

featured

Zacks Investment Research

Is IBRX Priced for Perfection at Nearly 28x Forward Sales?

featured

Zacks Investment Research

What Makes ImmunityBio (IBRX) a New Buy Stock

featured

ImmunityBio Stock Rises As ANKTIVA Launches in Saudi Arabia

featured

Reframing ImmunityBio: The Long-Term Platform Opportunity Beyond Anktiva

featured

Zacks Investment Research

IBRX Stock Rises 7% on Strong Q1 2026 Preliminary Results

featured

Why Is ImmunityBio Stock Rallying Thursday?

Advertisement

Advertisement

Advertisement